NCT03865199 is a NA clinical trial of Narrative Intervention in Stigma, Social, sponsored by University of Chicago.

Who is sponsoring NCT03865199?

NCT03865199 is sponsored by University of Chicago.

What drugs are being tested in NCT03865199?

Interventions in NCT03865199: Narrative Intervention.

What condition does NCT03865199 study?

NCT03865199 studies Stigma, Social.

Is NCT03865199 still recruiting?

NCT03865199 is currently completed. Last updated 20 April 2020.

Last reviewed 2020-04-20 · How we verify

NCT03865199

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

A Narrative Intervention to Decrease Abortion Stigma

Completed NA Last updated 20 April 2020

What this trial tests

NA trial testing Narrative Intervention in Stigma, Social in 215 participants. Completed in 5 February 2020.

Timeline

16 June 2019

Primary endpoint
5 February 2020

5 February 2020

Quick facts

Lead sponsor	University of Chicago
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	supportive care
Enrollment	215
Start date	16 June 2019
Primary completion	5 February 2020
Estimated completion	5 February 2020
Sites	1 location across United States

Drugs / interventions tested

Narrative Intervention

Conditions studied

Stigma, Social — all drugs for Stigma, Social →

Sponsor

University of Chicago

Who can join

18 and older, female only, with Stigma, Social. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Abortion stigma is pervasive in the United States. It operates across multiple levels, including the individual, community, and structural. While abortion itself does not cause mental health problems, due to stigma, women who undergo abortion are at risk of suffering negative psychological responses including thought suppression and isolation, which can result in psychological distress. Few intervention studies have addressed abortion stigma. Research in other disciplines, in particular mental health, has demonstrated the importance of self-validation in improved coping. Drawing from psychologists' use of writing in cognitive therapy and the discipline of Narrative Medicine's emphasis on narrative as a mechanism of healing, the proposed study attempts to test a novel intervention to reduce individual level abortion stigma. The study will be a randomized controlled trial evaluating a narrative intervention to reduce individual level abortion stigma. The principal research question is: can a narrative intervention that aims to positively frame the abortion experience decrease individual level abortion stigma? An additional research question is: will women who take part in a narrative intervention to reduce abortion stigma have improved psychological responses to the abortion? Women in the intervention group will view a digital story on a tablet intending to provide education and normalization and then respond to a writing prompt aimed at cognitive restructuring. The control group will receive care as usual.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Narrative Intervention

Trials testing the same drug.

NCT04118569 — Personalized Experiences to Inform Improved Communication for Patients With Life Limiting Illness · NA · completed

Other recruiting trials for Stigma, Social

Currently open trials in the same condition.

NCT07430761 — ET Stigma Response to Tremor Suppression · recruiting
NCT04881084 — Exploring Empathy and Compassion Using Digital Narratives · NA · recruiting
NCT05174936 — ResIlience-based Stigma REdUction Program ("Rise-up") · NA · active not recruiting
NCT05704764 — Using the Ending Self-Stigma Intervention to Reduce Internalized Stigma Among People Living With HIV Who Use Substances · NA · active not recruiting
NCT05404750 — Harm Reduction in HIV Primary Care for PLWH Who Use Drugs · recruiting

Other University of Chicago trials

Trials by the same sponsor.

NCT07346196 — A Trial of Locoregionally Advanced Squamous Cell Carcinoma of The Head and Neck · Phase 2 · not yet recruiting
NCT07354100 — Lactulose to Improve Gut Health in Cancer Patients Receiving Immunotherapy · Phase 1, PHASE2 · not yet recruiting
NCT06446661 — Using Text Messages to Improve Oral Chemotherapy for Adolescents and Adults With Acute Lymphoblastic Leukemia · NA · not yet recruiting
NCT07179315 — A Study Comparing Two Immunotherapy Options for Human Papillomavirus Positive HPV-Positive Head and Neck Cancer After Tr · Phase 2 · not yet recruiting
NCT07126561 — Trastuzumab Deruxtecan to Treat HER2 + Newly Diagnosed Metastatic GI Cancers · Phase 2 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03865199 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Chicago
Last refreshed: 20 April 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03865199.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing